GL1X · GenesisL1 explorer

MolNFT v1 · #111828 · protein

The structure of human PDE12 residues 161-609 in complex with GSK3036342A

4Z2B · 2',5'-phosphodiesterase 12: “The structure of human PDE12 residues 161-609 in complex with GSK3036342A”. X-ray diffraction, 3 ligands (4LC, MG, SO4), 4 pockets (best druggability 0.61). MolNFT v1 #111828 on GenesisL1: 3D structure…

PDB
4Z2B
Type
protein
Length
449 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
2',5'-phosphodiesterase 12
EC
3.1.4.-, 3.1.13.4
UniProt
Q6L8Q7
Ligands
4LC, MG, SO4
Pockets
4 · best druggability 0.61

Structure

x-ray diffraction · 1 distinct chain · 27% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A2',5'-phosphodiesterase 12 (EC 3.1.4.-, 3.1.13.4)protein44927% helix, 29% strandQ6L8Q7

Ligands and binding sites

  • 4LC · 3-(6-{[(2S,3S)-3-(hydroxymethyl)-2-phenylmorpholin-4-yl]carbonyl}-1-methyl-1H-benzimidazol-2-yl)-1H-indole-6-carbonitrile · ligand · chains A
  • MG · Magnesium ion · metal · chains A
  • SO4 · Sulfate ion · ion · chains A
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A
  • TRS · 2-amino-2-hydroxymethyl-propane-1,3-diol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13720.610.7741SO4, EDO, 4LC, MG
21180.550.8320empty
31170.440.7719empty
4590.290.7413empty

Compared structures

  • 4Z2B · The structure of human PDE12 residues 161-609 in complex with GSK3036342A · the same entry in another collection · chain A against A, TM-score 1.00
  • Q6L8Q7 · AlphaFold monomer V2.0 prediction for 2',5'-phosphodiesterase 12 (Q6L8Q7) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.